Related Experiment Video
Updated: Jul 9, 2026

07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Analytical validation of a high-resolution melting assay for UGT1A1 TATA-box polymorphisms
Stefano Gambarino1,2, Anna Clemente1,2, Anna Pau1,2
1Department of Public Health and Pediatric Sciences, Immunopathology Laboratory, Medical School, University of Turin, Turin, 10126, Italy.
Molecular Biology Reports
|July 8, 2026
Summary
A new High-Resolution Melting (HRM) assay accurately genotypes UGT1A1 TATA-box promoter variations, crucial for diagnosing Gilbert syndrome and predicting irinotecan toxicity in clinical settings.
Area of Science:
- Molecular Diagnostics
- Genetics
- Pharmacogenomics
Background:
- UGT1A1 promoter TATA-box polymorphisms are linked to Gilbert syndrome.
- These polymorphisms significantly influence irinotecan-related toxicity.
- There is a need for efficient and reliable genotyping methods in diagnostics.
Purpose of the Study:
- To analytically validate a High-Resolution Melting (HRM) assay for UGT1A1 TATA-box allele discrimination.
- To assess the assay's performance under routine diagnostic conditions using clinical samples.
Main Methods:
- Analytical validation using plasmid controls, reference genomic DNA, and Sanger sequencing confirmed samples.
- Testing of various UGT1A1 TATA-box genotypes (TA5, TA6, TA7, TA8) and heterozygotes.
- Assessment of assay reproducibility through intra-test and inter-test analyses.
Main Results:
- The HRM assay successfully discriminated tested UGT1A1 TATA-box genotypes based on melting temperature and curve morphology.
- Complete concordance was observed between HRM genotype calls and expected or reference genotypes.
- High reproducibility was demonstrated, with low coefficient of variation (CV) in melting temperature measurements.
Conclusions:
- The developed UGT1A1 TATA-box HRM assay provides reproducible genotype discrimination.
- This assay is a practical and potentially valuable tool for routine UGT1A1 promoter genotyping in molecular diagnostics.

